New Delhi [India], Jan. 18 (ANI): The Cabinet on Wednesday gave its approval to the proposal for India to take its full membership of the International Vaccine Institute (IVI) Governing Council.
Geneva [Switzerland], Dec. 24 (ANI): An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet.
Washington D.C. [USA], Dec. 20 (ANI): US researchers have developed a vaccine for chikungunya fever made from an insect-specific virus that does not have any effect on people, making the vaccine safe and effective.
Washington D.C [US], Nov.26 (ANI): According to a recent study, scientists have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone (oxy) and hydrocodone (hydro) in animal models.
Washington D.C. [USA], Oct. 22 (ANI): A study finds fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development.
Washington D.C. [USA], Sept. 13 (ANI): A recent study at The Scripps Research Institute (TSRI) shows that holes in HIV's defensive sugar shield could be important in designing an HIV vaccine.
Washington D.C, Aug 2 (ANI): A team of researchers has opened a door to influencing the immune system, which would be useful to boost the effectiveness of vaccines or to counter autoimmune diseases such as lupus and rheumatoid arthritis.
Washington D.C, Aug 1 (ANI): A team of scientists has identified immunological profiles of people who make powerful HIV antibodies, paving the way for development of a vaccine.
Washington D.C, Jul 23 (ANI): Every year, many people roll up their sleeves for a flu shot. Howbeit, the influenza virus has thousands of strains and the vaccine can't guard against all of them. But now, a team of researchers finally might be onto something.
Washington D.C, Jul 20 (ANI): World's first vaccine for an insidious sexual transmitted infection (STI) has come closer to reality in the form of a nose spray.
New Delhi, July 15 (ANI): A team from International AIDS Vaccine Initiative (IAVI), led by President and CEO, Mark Feinberg, will be encouraging the global response to end HIV at the 21st International AIDS Conference, in Durban, South Africa.